May 25, 2026  
2023-2024 Undergraduate Academic Catalog-June Update 
    
2023-2024 Undergraduate Academic Catalog-June Update [ARCHIVED CATALOG]

Add to Portfolio (opens a new window)

BIE 4200 - Engineering Controlled Drug Delivery and Nanomedicine

2 lecture hours 2 lab hours 3 credits
Course Description
This course addresses the engineering principles behind the development and understanding of controlled drug delivery systems and nanomedicine. This course focuses on understanding the drug delivery process and industrial-relevant techniques including nanotechnology used for the design of specific formulations. The topics range from general biological barriers to drug delivery and pharmacokinetics, synthetic drug/gene delivery vectors, targeted drug delivery to medical nanotechnology and nanomedicine. (prereq: BIE 3200 ) (quarter system prereq: EB 2250)
Course Learning Outcomes
Upon successful completion of this course, the student will be able to:
  • Discuss basic pharmacology, pharmacokinetics, and pharmacodynamics
  • Discuss the principles of prodrug design and design prodrugs as drug delivery systems
  • Discuss physiological and chemical barriers for drug delivery
  • Compare and design the carriers for drug delivery
  • Assess the emerging biomedical nanotechnology
  • Discuss molecular nanotechnology applications in pharmaceuticals and medicine
  • Discuss targeted drug delivery, especially to the brain and tumor
  • Design targeted drug delivery systems
  • Compare and select different controlled drug delivery systems and understand the FDA requirements for controlled release systems
  • Design controlled drug delivery systems under the FDA requirements

Prerequisites by Topic
  • Biopolymers, nanomaterials, and nanostructures
  • Biocompatibility and biocompatibility
  • Bionanotechnology and nanobiotechnology

Course Topics
  • Introduction to drug delivery
  • Pharmacology, pharmacokinetics, and pharmacodynamics
  • Physiological and biochemical barriers to drug delivery
  • Prodrugs as drug delivery
  • Engineered carriers and vectors in drug delivery
  • Diffusion-controlled drug delivery systems
  • Dissolution-controlled drug delivery systems
  • Erodible drug delivery systems
  • Osmotic-controlled drug delivery systems
  • Oral controlled-release delivery
  • The nature of nanotechnology (from nanoscience to nanotechnology)
  • Medical nanotechnology and nanomedicine
  • Special topic: design of nanoparticles for cancer treatment
  • Targeting approaches to drug delivery
  • Site-specific drug delivery
  • Market and FDA requirements for controlled release products

Laboratory Topics
  • Biopolymer purification to achieve the pharmaceutical grade
  • Drug stability
  • Alginate-based microcapsules preparation
  • Polymeric nanofiber preparation
  • Liposome preparation
  • Release profiles of encapsulated drugs
  • Biosynthesis of nanoparticles for pharmaceutical and biomedical application

Coordinator
Dr. Wujie Zhang



Add to Portfolio (opens a new window)